Eleven Biotherapeutics Announces Top-Lin...
From Eleven Biotherapeutics
Eleven Biotherapeutics announced top-line results from a phase 2 study of its lead drug candidate, EBI-005, in patients with moderate to severe allergic conjunctivitis. T... (Read more)
Protein Content in Compounded Bevacizuma...
From Medscape Ophthalmology
The protein concentration of bevacizumab prepared by U.S. compounding pharmacies for intravitreal injection shows significant variations, according to New York-based rese... (Read more)
Italian Research Provides Preliminary Ev...
From Medical News Today
The poster presented during the EuCornea Congress describes the preliminary results of the Phase I segment of the REPARO Study, a randomized, double-masked, placebo contr... (Read more)
Johnson & Johnson Vision Care Announces ...
From Johnson & Johnson Vision Care
Johnson & Johnson Vision Care announced that Acuvue Oasys brand contact lenses for astigmatism is now the first and only silicone hydrogel toric contact lens with -2.... (Read more)
Marco Expands its Management Team
Marco, a provider of diagnostic equipment for the eye care market, has announced it is expanding its management team. Below are descriptions of new management positions w... (Read more)
Subscribe to EyewireToday.com